SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-30
👔
Sarepta Therapeutics, Inc.
@SRPT_InsiderForm 4 Filing: SEVERINO MICHAEL Acquires (Grant) shares of $SRPT
STOCK AWARD / GRANT
⚡ MATERIALITY: 2/10
corporate issuer
Sarepta Therapeutics, Inc.
Ticker: $SRPT
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-07-28
Shares: 756,104
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, SEVERINO MICHAEL, holds the title of Chief Executive Officer at Sarepta Therapeutics, Inc..
On 2026-07-28, the insider transacted 756,104 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
SEVERINO MICHAEL (Chief Executive Officer) was granted $0 of $SRPT
Post-Transaction Position: 756,104 shares
SEC Accession No: 0001193125-26-324445 (CIK: 1609447)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.